Kiniksa Pharmaceuticals, Ltd.
- Trend: The stock has been in a strong uptrend since late June 2024, with the price rising from around $19 to a high of $27.88.
- Moving Averages: The price is currently above both the short-term (likely 50-day) and long-term (likely 200-day) moving averages, indicating bullish momentum.
- Support and Resistance:
➢Key resistance level around $27-28
➢Support levels at around $24 and $22 - Volume: There was a significant spike in trading volume in late July, coinciding with the sharp price increase. This suggests strong buying interest.
- Price Action: The stock has shown some consolidation recently after the sharp rise, forming a potential bull flag pattern.
- Volatility: Increased volatility is evident in the wider price ranges of recent candles compared to earlier periods.
- Indicators (based on visible chart elements):
➢The stock is trading above the upper Bollinger Band, suggesting it might be overbought in the short term.
➢The recent pullback has brought the price closer to the moving averages, potentially setting up for another move higher if support holds. - Overall Outlook: The chart appears bullish overall, but the stock may be due for a short-term pullback or consolidation after its recent strong run-up. Traders might watch for a potential breakout above the recent high of $27.88 or a deeper retracement to support levels.
➀➁➂➃➄
Aviso legal
As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.
➀➁➂➃➄
Aviso legal
As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.